Recruitment for Clinical Trial Coordinator at Homi Bhabha Cancer Hospital and MPMMCC
An open–label phase II trial evaluating the activity and safety of JDQ443 single agent as first-line treatment for patients with locally advanced or metastatic KRAS G12Cmutated non-small cell lung cancer